Literature DB >> 33709131

Guidance on Imaging for Invasive Pulmonary Aspergillosis and Mucormycosis: From the Imaging Working Group for the Revision and Update of the Consensus Definitions of Fungal Disease from the EORTC/MSGERC.

Barbara D Alexander1, Frédéric Lamoth2,3, Claus Peter Heussel4,5,6, Cornelia Schaefer Prokop7,8, Sujal R Desai9, C Orla Morrissey10, John W Baddley11.   

Abstract

BACKGROUND: Clinical imaging in suspected invasive fungal disease (IFD) has a significant role in early detection of disease and helps direct further testing and treatment. Revised definitions of IFD from the EORTC/MSGERC were recently published and provide clarity on the role of imaging for the definition of IFD. Here, we provide evidence to support these revised diagnostic guidelines.
METHODS: We reviewed data on imaging modalities and techniques used to characterize IFDs.
RESULTS: Volumetric high-resolution computed tomography (CT) is the method of choice for lung imaging. Although no CT radiologic pattern is pathognomonic of IFD, the halo sign, in the appropriate clinical setting, is highly suggestive of invasive pulmonary aspergillosis (IPA) and associated with specific stages of the disease. The ACS is not specific for IFD and occurs in the later stages of infection. By contrast, the reversed halo sign and the hypodense sign are typical of pulmonary mucormycosis but occur less frequently. In noncancer populations, both invasive pulmonary aspergillosis and mucormycosis are associated with "atypical" nonnodular presentations, including consolidation and ground-glass opacities.
CONCLUSIONS: A uniform definition of IFD could improve the quality of clinical studies and aid in differentiating IFD from other pathology in clinical practice. Radiologic assessment of the lung is an important component of the diagnostic work-up and management of IFD. Periodic review of imaging studies that characterize findings in patients with IFD will inform future diagnostic guidelines.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  aspergillosis; imaging; invasive fungal disease; mucormycosis; radiography

Year:  2021        PMID: 33709131     DOI: 10.1093/cid/ciaa1855

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  8 in total

Review 1.  Early pulmonary complications related to cancer treatment in children.

Authors:  Cara E Morin; Morgan P McBee; Lama Elbahlawan; Lindsay M Griffin; Gabriela M Maron; HaiThuy N Nguyen; Akshay Sharma; Elizabeth J Snyder; Jean Jeudy
Journal:  Pediatr Radiol       Date:  2022-07-02

Review 2.  Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary Sciences, India.

Authors:  Valliappan Muthu; Ritesh Agarwal; Atul Patel; Soundappan Kathirvel; Ooriapadickal Cherian Abraham; Ashutosh Nath Aggarwal; Amanjit Bal; Ashu Seith Bhalla; Prashant N Chhajed; Dhruva Chaudhry; Mandeep Garg; Randeep Guleria; Ram Gopal Krishnan; Arvind Kumar; Uma Maheshwari; Ravindra Mehta; Anant Mohan; Alok Nath; Dharmesh Patel; Shivaprakash Mandya Rudramurthy; Puneet Saxena; Nandini Sethuraman; Tanu Singhal; Rajeev Soman; Balamugesh Thangakunam; George M Varghese; Arunaloke Chakrabarti
Journal:  Lancet Infect Dis       Date:  2022-04-04       Impact factor: 71.421

3.  NLRP3, NLRC4 and NLRC5 Gene Polymorphisms Associate with Susceptibility of Pulmonary Aspergillosis in Non-Neutropenic Patients.

Authors:  Jinjin Zhong; Lulu Liu; Yajie Lu; Yu Gu; Jiangnan Zhao; Bilin Chen; Wei Zhou; Xin Su
Journal:  J Clin Med       Date:  2022-03-28       Impact factor: 4.241

Review 4.  Fungal infections diagnosis - Past, present and future.

Authors:  Alexandre Mendonça; Helena Santos; Ricardo Franco-Duarte; Paula Sampaio
Journal:  Res Microbiol       Date:  2021-12-01       Impact factor: 3.946

Review 5.  Invasive Respiratory Fungal Infections in COVID-19 Critically Ill Patients.

Authors:  Francesca Raffaelli; Eloisa Sofia Tanzarella; Gennaro De Pascale; Mario Tumbarello
Journal:  J Fungi (Basel)       Date:  2022-04-17

Review 6.  COVID-19 and Mucormycosis Coinfection: How Challenging It Is.

Authors:  Niranjan Nayak; Erum Khan; Debadatta Panigrahi
Journal:  Can J Infect Dis Med Microbiol       Date:  2022-04-07       Impact factor: 2.585

7.  Application of metagenomic next-generation sequencing in the diagnosis of pulmonary invasive fungal disease.

Authors:  Chengtan Wang; Zhiqing You; Juanjuan Fu; Shuai Chen; Di Bai; Hui Zhao; Pingping Song; Xiuqin Jia; Xiaoju Yuan; Wenbin Xu; Qigang Zhao; Feng Pang
Journal:  Front Cell Infect Microbiol       Date:  2022-09-27       Impact factor: 6.073

Review 8.  Diagnosis of Pneumonia Due to Invasive Molds.

Authors:  Carlo Foppiano Palacios; Anne Spichler Moffarah
Journal:  Diagnostics (Basel)       Date:  2021-07-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.